Tauopathies
Subject Vocabulary
MeSH
Unique ID
D024801
Valentino, R. R., Scotton, W. J., Roemer, S. F., Lashley, T., Heckman, M. G., Shoai, M., Martinez-Carrasco, A., Tamvaka, N., Walton, R. L., Baker, M. C., Macpherson, H. L., Real, R., Soto-Beasley, A. I., Mok, K., Revesz, T., Christopher, E. A., DeTure, M., Seeley, W. W., Lee, E. B., … Wszolek, Z. K. (2024). MAPT H2 haplotype and risk of Pick’s disease in the Pick’s disease International Consortium: a genetic association study. The Lancet Neurology, 23(5), 487–499. https://doi.org/10.1016/s1474-4422(24)00083-8
Subjects:
Pick Disease of the Brain
(MeSH)
Tauopathies
(MeSH)
Grants:
P30AG062422
(NIH – National Institute On Aging)
P30AG013854
(NIH – National Institute On Aging)
P30AG072977
(NIH – National Institute On Aging)
R01AG077444
(NIH – National Institute On Aging)
Publication Type:
Article
Unique ID:
10.1016/s1474-4422(24)00083-8
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Kim, Y. A., Mellen, M., Kizil, C., & Santa‐Maria, I. (2023). Mechanisms linking cerebrovascular dysfunction and tauopathy: Adding a layer of epiregulatory complexity. British Journal of Pharmacology, 181(6), 879–895. Portico. https://doi.org/10.1111/bph.16280
Subjects:
Alzheimer Disease
(MeSH)
Tauopathies
(MeSH)
Publication Type:
Article
Unique ID:
10.1111/bph.16280
PMID:
DOI:
Journal:
Publication Date:
Data Source:
PubMed
Source Link:
Record Created:
Focusing on oligomeric tau as a therapeutic target in Alzheimer's disease and other tauopathies
Rayman, J. B. (2023). Focusing on oligomeric tau as a therapeutic target in Alzheimer’s disease and other tauopathies. Expert Opinion on Therapeutic Targets, 27(4–5), 269–279. https://doi.org/10.1080/14728222.2023.2206561
Subjects:
Publication Type:
Article
Unique ID:
10.1080/14728222.2023.2206561
PMID:
Publication Date:
Data Source:
PubMed
Source Link:
Record Created:
Du, F., Yu, Q., Kanaan, N. M., & Yan, S. S. (2022). Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer’s disease. Human Molecular Genetics, 31(15), 2498–2507. https://doi.org/10.1093/hmg/ddab363
Subjects:
Alzheimer Disease
(MeSH)
Tauopathies
(MeSH)
Grants:
RF1AG054320
(NIH – National Institute On Aging)
R01AG069426
(NIH – National Institute On Aging)
Publication Type:
Article
Unique ID:
10.1093/hmg/ddab363
PMID:
DOI:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia
Guisle, I., Canet, G., Pétry, S., Fereydouni-Forouzandeh, P., Morin, F., Kérauden, R., Whittington, R. A., Calon, F., Hébert, S. S., & Planel, E. (2022). Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia. Neurobiology of Aging, 113, 118–130. https://doi.org/10.1016/j.neurobiolaging.2022.02.011
Columbia Affiliation:
Subjects:
Publication Type:
Article
Unique ID:
10.1016/j.neurobiolaging.2022.02.011
PMID:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Wolframin is a novel regulator of tau pathology and neurodegeneration
Chen, S., Acosta, D., Li, L., Liang, J., Chang, Y., Wang, C., Fitzgerald, J., Morrison, C., Goulbourne, C. N., Nakano, Y., Villegas, N. C. H., Venkataraman, L., Brown, C., Serrano, G. E., Bell, E., Wemlinger, T., Wu, M., Kokiko-Cochran, O. N., Popovich, P., … Fu, H. (2022). Wolframin is a novel regulator of tau pathology and neurodegeneration. Acta Neuropathologica, 143(5), 547–569. https://doi.org/10.1007/s00401-022-02417-4
Subjects:
Alzheimer Disease
(MeSH)
Tauopathies
(MeSH)
Grants:
P30DK020579
(NIH – National Institute of Diabetes and Digestive and Kidney Diseases)
R01GM131399
(NIH – National Institute of General Medical Sciences)
K01AG056673
(NIH – National Institute On Aging)
R56AG066782
(NIH – National Institute On Aging)
R01AG075092
(NIH – National Institute On Aging)
R01AG014452
(NIH – National Institute On Aging)
Publication Type:
Article
Unique ID:
10.1007/s00401-022-02417-4
PMID:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Genome-wide association study and functional validation implicates JADE1 in tauopathy
Farrell, K., Kim, S., Han, N., Iida, M. A., Gonzalez, E. M., Otero-Garcia, M., Walker, J. M., Richardson, T. E., Renton, A. E., Andrews, S. J., Fulton-Howard, B., Humphrey, J., Vialle, R. A., Bowles, K. R., de Paiva Lopes, K., Whitney, K., Dangoor, D. K., Walsh, H., Marcora, E., … Crary, J. F. (2021). Genome-wide association study and functional validation implicates JADE1 in tauopathy. Acta Neuropathologica, 143(1), 33–53. https://doi.org/10.1007/s00401-021-02379-z
Subjects:
Grants:
R01CA079830
(NIH – National Cancer Institute)
UL1TR001414
(NIH – National Center for Advancing Translational Sciences)
R01NS086736
(NIH – National Institute of Neurological Disorders and Stroke)
R01NS095252
(NIH – National Institute of Neurological Disorders and Stroke)
U24NS072026
(NIH – National Institute of Neurological Disorders and Stroke)
K23NS109284
(NIH – National Institute of Neurological Disorders and Stroke)
U54NS115266
(NIH – National Institute of Neurological Disorders and Stroke)
P30NS055077
(NIH – National Institute of Neurological Disorders and Stroke)
P50AG005138
(NIH – National Institute On Aging)
P30AG010124
(NIH – National Institute On Aging)
K99AG070109
(NIH – National Institute On Aging)
P50AG016573
(NIH – National Institute On Aging)
P30AG066444
(NIH – National Institute On Aging)
P30AG010161
(NIH – National Institute On Aging)
R01AG062348
(NIH – National Institute On Aging)
P50AG025688
(NIH – National Institute On Aging)
P30AG066514
(NIH – National Institute On Aging)
P30AG013854
(NIH – National Institute On Aging)
F32AG056098
(NIH – National Institute On Aging)
P01AG026276
(NIH – National Institute On Aging)
K08AG065463
(NIH – National Institute On Aging)
P30AG072946
(NIH – National Institute On Aging)
U01AG006781
(NIH – National Institute On Aging)
R01AG054449
(NIH – National Institute On Aging)
P01AG000538
(NIH – National Institute On Aging)
U01AG058635
(NIH – National Institute On Aging)
RF1AG060961
(NIH – National Institute On Aging)
R01AG066152
(NIH – National Institute On Aging)
P50AG005136
(NIH – National Institute On Aging)
U24AG021886
(NIH – National Institute On Aging)
P30AG008017
(NIH – National Institute On Aging)
P30AG066509
(NIH – National Institute On Aging)
P50AG005134
(NIH – National Institute On Aging)
P01AG017586
(NIH – National Institute On Aging)
P30AG066462
(NIH – National Institute On Aging)
P30AG072979
(NIH – National Institute On Aging)
P50AG005681
(NIH – National Institute On Aging)
U19AG062418
(NIH – National Institute On Aging)
P01AG003991
(NIH – National Institute On Aging)
P50AG008702
(NIH – National Institute On Aging)
P30AG066511
(NIH – National Institute On Aging)
P30AG072977
(NIH – National Institute On Aging)
P30AG066507
(NIH – National Institute On Aging)
P50AG005131
(NIH – National Institute On Aging)
P50AG005146
(NIH – National Institute On Aging)
R01AG059848
(NIH – National Institute On Aging)
P30AG062429
(NIH – National Institute On Aging)
P30AG062421
(NIH – National Institute On Aging)
P30AG066468
(NIH – National Institute On Aging)
R01AG021055
(NIH – National Institute On Aging)
P30AG028383
(NIH – National Institute On Aging)
P30AG072980
(NIH – National Institute On Aging)
P30AG066519
(NIH – National Institute On Aging)
P01AG066597
(NIH – National Institute On Aging)
P30AG019610
(NIH – National Institute On Aging)
R01AG054008
(NIH – National Institute On Aging)
S10OD030463
(NIH – Office of the Director, National Institutes of Health)
S10OD026880
(NIH – Office of the Director, National Institutes of Health)
Publication Type:
Article
Unique ID:
10.1007/s00401-021-02379-z
PMID:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies
Kim, S. H., Farrell, K., Cosentino, S., Vonsattel, J.-P. G., Faust, P. L., Cortes, E. P., Bennet, D. A., Louis, E. D., & Crary, J. F. (2021). Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies. Journal of Neuropathology & Experimental Neurology, 80(9), 835–843. https://doi.org/10.1093/jnen/nlab073
Subjects:
Deep Brain Stimulation for Neurological Disorders
(OpenAlex Topic)
Mechanisms of Alzheimer's Disease
(OpenAlex Topic)
Pathophysiology of Parkinson's Disease
(OpenAlex Topic)
Brain
(MeSH)
Essential Tremor
(MeSH)
Tauopathies
(MeSH)
tau Proteins
(MeSH)
Grants:
P30NS055077
(NIH – National Institute of Neurological Disorders and Stroke)
P50AG016573
(NIH – National Institute On Aging)
P50AG005133
(NIH – National Institute On Aging)
Publication Type:
Article
Unique ID:
10.1093/jnen/nlab073
PMID:
DOI:
Publication Date:
Data Source:
Scopus
Record Created:
Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults
Palta, P., Rippon, B., Tahmi, M., Pardo, M., Johnson, A., Tomljanovic, Z., He, H., Laing, K. K., Razlighi, Q. R., Teresi, J. A., Moreno, H., Brickman, A. M., Kreisl, W. C., & Luchsinger, J. A. (2021). Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults. Neurobiology of Aging, 103, 109–116. https://doi.org/10.1016/j.neurobiolaging.2021.03.007
Columbia Affiliation:
Subjects:
Grants:
UL1TR001873
(NIH – National Center for Advancing Translational Sciences)
R00AG052830
(NIH – National Institute On Aging)
P30AG059303
(NIH – National Institute On Aging)
R01AG050440
(NIH – National Institute On Aging)
K24AG045334
(NIH – National Institute On Aging)
RF1AG051556
(NIH – National Institute On Aging)
Publication Type:
Article
Unique ID:
10.1016/j.neurobiolaging.2021.03.007
PMID:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease
Kang, S. S., Ahn, E. H., Liu, X., Bryson, M., Miller, G. W., Weinshenker, D., & Ye, K. (2021). ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease. Acta Neuropathologica, 142(1), 139–158. https://doi.org/10.1007/s00401-021-02315-1
Columbia Affiliation:
Subjects:
Grants:
UL1TR002378
(NIH – National Center for Advancing Translational Sciences)
P30NS055077
(NIH – National Institute of Neurological Disorders and Stroke)
RF1AG061175
(NIH – National Institute On Aging)
RF1AG051538
(NIH – National Institute On Aging)
Publication Type:
Article
Unique ID:
10.1007/s00401-021-02315-1
PMID:
Journal:
Publication Date:
Data Source:
Scopus
Record Created:
Schaler, A. W., Runyan, A. M., Clelland, C. L., Sydney, E. J., Fowler, S. L., Figueroa, H. Y., Shioda, S., Santa-Maria, I., Duff, K. E., & Myeku, N. (2021). PAC1 receptor–mediated clearance of tau in postsynaptic compartments attenuates tau pathology in mouse brain. Science Translational Medicine, 13(595). https://doi.org/10.1126/scitranslmed.aba7394
Subjects:
Tauopathies
(MeSH)
tau Proteins
(MeSH)
Grants:
R01NS095922
(NIH – National Institute of Neurological Disorders and Stroke)
R01AG064244
(NIH – National Institute On Aging)
K01AG055694
(NIH – National Institute On Aging)
Publication Type:
Article
Unique ID:
10.1126/scitranslmed.aba7394
PMID:
Journal:
Publication Date:
Data Source:
PubMed